LOGIN
Increase in BMD with zoledronic acid in elderly women with osteoporosis and living in LTC
September 2015
Increase in BMD with zoledronic acid in elderly women with osteoporosis and living in LTC
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
Efficacy and safety of single-dose zoledronic acid for osteoporosis in frail elderly women: a randomized clinical trial
JAMA Intern Med. 2015 Jun;175(6):913-21Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
181 elderly women with osteoporosis or bone fractures were randomized to receive either one 5-mg dose of zoledronic acid or placebo intravenously. The purpose of this study was to determine whether zoledronic acid was safe and effective for improving bone mineral density in frail elderly women with osteoporosis. Hip and spine bone mineral density were measured at 12 and 24 months post-intervention...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.